|
correlation between serum Vitamin D3 Level and Disease Severity in the Patients with Chronic Obstructive Pulmonary Disease (COPD)
|
Sahar Rezaei nejad    1, Hamid Bakhshi aliabad2 , Hosein Basirat3 , Haniye Maleki4 , Fatemeh Amin5 , Mahdi Karimi6 |
1- General surgery resident, department of general surgery, shiraz uni. Med. Science , srezaei_89@yahoo.com
2- Continue Medical education center. Rafsanjan university of medical sciences, Rafsanjan, Iran
3- Rafsanjan university of medical sciences, Rafsanjan, Iran.
4- Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
5- Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
6- Department of Internal Medicine, School of Medicine' Rafsanjan University of Medical Sciences, Rafsanjan, Iran |
|
|
Abstract: (432 Views) |
Background and Aim: Chronic obstructive pulmonary disease (COPD) which is characterized by symptoms such as dyspnea and cough is the fourth leading cause of death worldwide. Limited studies have shown that vitamin D3 can have a positive impact on reducing the disease severity and preventing exacerbations in the patients with COPD. Therefore, in this study we evaluated the correlation of the serum vitamin D3 level with the severity of disease in COPD patients referring to the clinic of Ali-Ibn Abi Talib Hospital in Rafsanjan in 2015-2016.
Materials and Methods: This descriptive-correlational study included 70 patients with COPD. Diagnosis of COPD was confirmed by spirometry. In all patients, serum vitamin D3 level was measured then variables such as the severity of the disease (from spirometry score in GOLD criteria), the severity of dyspnea according to MRC dyspnea scale and the number of exacerbations were measured. Using software SPSS 20, data were analyzed by Spearman correlation.
Results: Among 70 COPD patients, 17 (24.2%) had severe vitamin D3 deficiency and 21 (30%) had insufficient vitamin D3 level. Significant moderate correlation was observed between the serum vitamin D3 level and severity of the disease based on the results of spirometry (r=0.587 and p=0.000). Also, vitamin D3 level showed significant inverse relationships with the frequency of exacerbations (p = 0.000) and the severity of dyspnea (p = 0.05).
Conclusion: The study findings indicated that vitamin D3 deficiency among COPD patients was prevalent. Moreover, there was a clear association between vitamin D3 deficiency and the severity of COPD. Therefore, treatment of vitamin D3 deficiency can potentially prevent the severity and frequency of exacerbations in these patients.
|
|
| Keywords: Chronic obstructive pulmonary disease, Vitamin D3, Severity of disease, Number of attacks |
|
|
Full-Text [PDF 990 kb]
(57 Downloads)
|
Type of Study: Original Research |
Subject:
Internal Medicine
Received: 2022/10/17 | Accepted: 2023/04/14 | Published: 2024/02/6
|
|
|
|
|
|
|
| References |
|
1. 1.Kasper DL BE, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. 19th ed.: New York: McGraw-Hill Medical Publishing Division; 2015. 2. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691-706. [ DOI:10.1016/S2213-2600(17)30293-X] [ PMID] 3. World Health Organization. Projections of mortality and causes of death, 2016 and 2060. Available from: https://www.who.int/healthinfo/global_burden_disease/projections_method.pdf. Accessed February 26, 2022. 4. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-65. [ DOI:10.1164/rccm.201204-0596PP] [ PMID] 5. The Global Strategy for Diagnosis, Management and Prevention of COPD (updated 2021), the Pocket Guide (updated 2021) and the complete list of references examined by the Committee is available on the GOLD website: www.goldcopd.org. 6. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):1504-20. [ DOI:10.1183/09031936.00070914] [ PMID] 7. Fonseca Wald ELA, van den Borst B, Gosker HR, Schols A. Dietary fibre and fatty acids in chronic obstructive pulmonary disease risk and progression: a systematic review. Respirology. 2014;19(2):176-84. [ DOI:10.1111/resp.12229] [ PMID] 8. Varraso R, Willett WC, Camargo CA, Jr. Prospective study of dietary fiber and risk of chronic obstructive pulmonary disease among US women and men. Am J Epidemiol. 2010;171(7):776-84. [ DOI:10.1093/aje/kwp455] [ PMID] [ ] 9. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8. [ DOI:10.1210/jc.2010-2704] [ PMID] [ ] 10. Fletcher JM, Basdeo SA, Allen AC, Dunne PJ. Therapeutic use of vitamin D and its analogues in autoimmunity. Recent Pat Inflamm Allergy Drug Discov. 2012;6(1):22-34. [ DOI:10.2174/187221312798889239] [ PMID] 11. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184(2):965-74. [ DOI:10.4049/jimmunol.0902840] [ PMID] [ ] 12. Rafiq R, Prins HJ, Boersma WG, Daniels JM, den Heijer M, Lips P, et al. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial. Int J Chron Obstruct Pulmon Dis. 2017;12:2583-92. [ DOI:10.2147/COPD.S132117] [ PMID] [ ] 13. Mekov E, Slavova Y, Tsakova A, Genova M, Kostadinov D, Minchev D, et al. Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients. PLoS One. 2015;10(6):e0129080. [ DOI:10.1371/journal.pone.0129080] [ PMID] [ ] 14. Lokesh KS, Chaya SK, Jayaraj BS, Praveena AS, Krishna M, Madhivanan P, et al. Vitamin D deficiency is associated with chronic obstructive pulmonary disease and exacerbation of COPD. Clin Respir J. 2021;15(4):389-99. [ DOI:10.1111/crj.13310] [ PMID] [ ] 15. Ferrari R, Caram LMO, Tanni SE, Godoy I, Rupp de Paiva SA. The relationship between Vitamin D status and exacerbation in COPD patients- a literature review. Respir Med. 2018;139:34-8. [ DOI:10.1016/j.rmed.2018.04.012] [ PMID] 16. Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; 2021. Available from: http://www.goldcopd.org. Accessed February 15, 2022. 17. Launois C, Barbe C, Bertin E, Nardi J, Perotin JM, Dury S, et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med. 2012;12:61. [ DOI:10.1186/1471-2466-12-61] [ PMID] [ ] 18. Holick. Vitamin D Physiology, Molecular Biology, and Clinical Applications. 2nd ed. New York: Humana Press; 2010. [ DOI:10.1007/978-1-60327-303-9] 19. Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019;74(4):337-45. [ DOI:10.1136/thoraxjnl-2018-212092] [ PMID] 20. Romme EAPM, Rutten EPA, Smeenk FWJM, Spruit MA, Menheere PPCA, Wouters EFM. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med. 2013;45(1):91-6. [ DOI:10.3109/07853890.2012.671536] [ PMID] 21. Vierucci F, Del Pistoia M, Fanos M, Erba P, Saggese G. Prevalence of hypovitaminosis D and predictors of vitamin D status in Italian healthy adolescents. Ital J Pediatr. 2014;40(1):54. [ DOI:10.1186/1824-7288-40-54] [ PMID] [ ] 22. Zhu M, Wang T, Wang C, Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2597. [ DOI:10.2147/COPD.S101382] [ PMID] [ ] 23. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-38. [ DOI:10.1056/NEJMoa0909883] [ PMID] 24. Lee CY, Shin SH, Choi HS, Im Y, Kim BG, Song JY, et al. Association Between Vitamin D Level and Respiratory Symptoms in Patients with Stable Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022;17:579-90. [ DOI:10.2147/COPD.S326037] [ PMID] [ ] 25. Zhu B, Zhu B, Xiao C, Zheng Z. Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1907-16. [ DOI:10.2147/COPD.S89763] [ PMID] [ ] 26. Wei R, Christakos S. Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D. Nutrients. 2015;7(10):8251-60. [ DOI:10.3390/nu7105392] [ PMID] [ ] 27. Bulut S, Karamanli H, ŞAhİN ME, ÇElİK D, BİBer Ç. Association between vitamin D levels and frequency of disease exacerbations and hospitalizations in patients with COPD. J health sci medicine. 2022;5(2):471-7. [ DOI:10.32322/jhsm.1050722] 28. Guevara MA, Lu J, Moore RE, Chambers SA, Eastman AJ, Francis JD, et al. Vitamin D and Streptococci: The Interface of Nutrition, Host Immune Response, and Antimicrobial Activity in Response to Infection. ACS Infect Dis. 2020;6(12):3131-40. [ DOI:10.1021/acsinfecdis.0c00666] [ PMID] [ ] 29. Wang Y, Wang J, Chen L, Zhang H, Yu L, Chi Y, et al. Efficacy of vitamin D supplementation on COPD and asthma control: A systematic review and meta-analysis. J Glob Health. 2022;12:04100. [ DOI:10.7189/jogh.12.04100] [ PMID] [ ] 30. Ghodrati S, Ezzatpanah A, Asadi-Khiavi M, Alian Samakkah S, Esmaeilzadeh A, Pezeshgi A. Administration of vitamin D to ameliorate dyspnea of chronic obstructive pulmonary disease patients: a randomized controlled trial. Immunopathol Persa. 2019;5(2):e22-e. [ DOI:10.15171/ipp.2019.22] 31. Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflamm Res. 2014;63(10):803-19. [ DOI:10.1007/s00011-014-0755-z] [ PMID] [ ] 32. Bikle DD. Vitamin D Regulation of Immune Function. Curr Osteoporos Rep. 2022;20(3):186-93. [ DOI:10.1007/s11914-022-00732-z] [ PMID] [ ] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Ethics code: IR.RUMS.REC.1394.205
rezaei nejad S, bakhshi aliabad H, basirat H, maleki H, amin F, karimi M. correlation between serum Vitamin D3 Level and Disease Severity in the Patients with Chronic Obstructive Pulmonary Disease (COPD). SJKU 2024; 28 (6) :65-75 URL: http://sjku.muk.ac.ir/article-1-7624-en.html
|
